C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 473/06 (2006.01) A61K 31/495 (2006.01) A61P 25/00 (2006.01) C07D 473/04 (2006.01)
Patent
CA 2672692
Disclosed are novel compounds of the general formula (Ia), and pharmaceutically acceptable salts, isomers, diastereomers or enantiomers thereof (Ia) and their use as medicines, for example in the treatment of dopamine-related movement disorders.
La présente invention concerne de nouveaux composés de formule générale (Ia), et leurs sels, isomères, diastéréomères ou enantiomères pharmaceutiquement acceptables ainsi que leur utilisation en tant que médicaments, par exemple dans le traitement de troubles du mouvement liés à la dopamine.
Burbiel Joachim
Hockemeyer Joerg
Mueller Christa
Tzvetkov Nikolay
Robic
Schwarz Pharma Ag
Ucb Pharma Gmbh
LandOfFree
8-ethinylxanthine derivatives as selective a2a receptor... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 8-ethinylxanthine derivatives as selective a2a receptor..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 8-ethinylxanthine derivatives as selective a2a receptor... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1409438